Brachytherapy
Volume 8, Issue 4 , Pages 385-391 , October 2009

Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer

  • Ly Do

      Affiliations

    • Department of Radiation Oncology, University of California Davis, Sacramento, CA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, University of California Davis, 4501 X Street, Suite G-140, Sacramento, CA 95817. Tel.: +1-916-734-8252; fax: +1-916-703-5069.
    • ,
  • Ajmel Puthawala

      Affiliations

    • Department of Radiation Oncology Long Beach Memorial Medical Center, Long Beach, CA
    • ,
  • Nisar Syed

      Affiliations

    • Department of Radiation Oncology Long Beach Memorial Medical Center, Long Beach, CA

Received 26 January 2009 ,Revised 19 March 2009 ,Accepted 25 March 2009.

References 

  1. Amdur RJ, Parsons JT, Mendenhall WM. Postoperative irradiation of for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys. 1989;16:25–36
  2. Bernier J, Domenge C, Ozsahin M. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–1952
  3. Cooper JS, Pajak TF, Forastiere AA. Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–1944
  4. Denis F, Garaud P, Bardet E. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol. 2004;22:69–76
  5. Jeremic B, Shibamoto Y, Stanisavljevic B. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol. 1997;43:29–37
  6. Adelstein DJ, Saxton JP, Lavertu P. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in respectable stage III and IV squamous cell head and neck cancer. Preliminary results. Head Neck. 1997;19:567–575
  7. Soo KC, Tan EH, Wee J. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: A randomized comparison. Br J Cancer. 2005;93:279–286
  8. Do L, Puthawala A, Syed N. T4 locally advanced head and neck cancer treatment outcomes of patients treated with resection followed by radiotherapy or chemoradiotherapy versus patients treated with concurrent chemoradiotherapy alone. Am J Clin Oncol. 2009;June 5 [Epub ahead of print]
  9. Samant S, Robbins KT, Kumar P. Bone or cartilage invasion by advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001;127:1451
  10. Puthawala AA, Syed AM, Eads DL. Limited external beam and interstitial 192 iridium irradiation in the treatment of carcinoma of the base of tongue: A ten year experience. Int J Radiat Oncol Biol Phys. 1988;14:839–848
  11. Puthawala AA, Syed AM, Eads DL. Limited external beam and interstitial 192 iridium irradiation in the treatment of squamous cell carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 1985;11:1595–1602
  12. Gibbs IC, Le QT, Shah RD. Long term outcomes after external beam irradiation and brachytherapy boost for base of tongue cancers. Int J Radiat Oncol Biol Phys. 2003;57:489–494
  13. Chen J, Pappas L, Moeller MS. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck. 2007;29:362–369
  14. Bhalavat RL, Pathak KA, Mahantshetty U. Brachytherapy boost: A novel approach for epiglottic carcinoma. Brachytherapy. 2007;6:212–217
  15. Karakoyun-Celik O, Norris CM, Tishler R. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005;27:353–361
  16. Inoue T, Inoue T, Teshima T. Phase III trial of high and low dose rate interstitial radiotherapy for early stage oral tongue cancer. Int J Radiat Oncol Biol Phys. 1996;36:1201–1204
  17. American Joint Committee on Cancer . AJCC Cancer Staging Handbook. 6th ed.. New York: Springer-Verlag; 2002;
  18. Hitt R, Lopez-Pousa A, Martinez-Trufero J. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2005;23:8636
  19. Vermorken JB, Remenar E, van Herpen C. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–1704
  20. Posner MR, Hershock DM, Blajman CR. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–1715
  21. Cmelak AJ, Li S, Goldwasser MA. Phase II trial of chemoradiation for organ preservation in respectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: Results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol. 2007;25:3971–3977
  22. Yousem DM, Gad K, Tufano RP. Resectability issues with head and neck cancer. Am J Neuroradiol. 2006;27:2024–2036
  23. Mendenhall WM, Stringer SP, Amdur RJ. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?. J Clin Oncol. 2000;18:35–42
  24. Jaulerry C, Rodriguez J, Brunin F. Results of radiation therapy in carcinoma of the base of tongue. The Curie Institute experience with about 166 cases. Cancer. 1991;67:1532–1538
  25. Nose T, Koizumi M, Nishiyama K. High dose rate interstitial brachytherapy for oropharyngeal carcinoma: Results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys. 2004;59:983–991
  26. Levendag P, Nijdam W, Noever I. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: Late adverse sequalae and performance status: Can we be more selective and obtain better tissue sparing?. Int J Radiat Oncol Biol Phys. 2004;59:713–724
  27. Yoshimura R, Shibuya H, Miura M. Quality of life of oral cancer patients after low dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:772–778
  28. Nijdam WM, Levendag PC, Noever I. Longitudinal changes in quality of life and costs in long term survivors of tumors of the oropharynx treated with brachytherapy or surgery. Brachytherapy. 2008;7:343–350
  29. Schliaphake H, Jamil MU. Prospective evaluation of quality of life after oncologic surgery for oral cancer. Int J Oral Maxillofac Surg. 2002;31:427–433
  30. De Graeff A, De Leeuw JRJ, Ros WJG. A prospective study on the quality of life of patients with cancer of the oral cavity or oropharynx with or without radiotherapy. Oral Oncol. 1999;35:27–32
  31. Eisbruch A, Lyden T, Bradford CR. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23–28
  32. Graner DE, Foote RL, Kasperbauer JL. Shallow function in patients before and after intra-arterial chemoradiation. Laryngoscope. 2003;113:573–579
  33. Kotz T, Costello R, Li Y. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck. 2004;26:365–372
  34. Carrara-de Angelis E, Feher O, Barros AP. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg. 2003;129:733–738
  35. Mittal BB, Pauloski BR, Haraf DJ. Swallowing dysfunction-preventative and rehabilitation strategies in patients with head and neck cancers treated with surgery, radiotherapy and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys. 2003;57:1219–1230
  36. Feng FY, Lyden TH, Kim HM. IMRT aimed at reducing dysphagia: Early dose volume effect relationships for swallowing structures. Int J Radiat Oncol Biol Phys. 2006;66:S44–S45
  37. Jensen K, Lambertsen K, Grau C. Dysphagia, aspiration and speech problems after radiotherapy for pharyngeal cancer correlate with dose volume parameters of the supraglottic region. Radiother Oncol. 2006;81:S167
  38. Eisbruch A, Lyden T, Bradford T. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys. 2004;60:1425–1439
  39. Eisbruch A, Levendag PC, Feng FY. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys. 2007;69:S40–S42
  40. Nijdam W, Levendag P, Noever I. Cancer in the oropharynx: Cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol. 2005;77:65–72
  41. Nijdam W, Levendag P, Noever I. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Int J Radiat Oncol Biol Phys. 2004;59:488–494
  42. Jereczek-Fossa BA, Orrechia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev. 2002;28:65–74

 Conflicts of interest: There are no actual or potential conflicts of interest.

PII: S1538-4721(09)00248-7

doi: 10.1016/j.brachy.2009.03.191

Brachytherapy
Volume 8, Issue 4 , Pages 385-391 , October 2009

Article Tools

* Image Usage & Resolution